Acute Lymphocytic Leukaemia
Showing 1 - 25 of >10,000
Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)
Recruiting
- Non-hodgkin Lymphoma
- +2 more
- CC312
-
Tianjin, Tianjin, ChinaInstituteHBDH
Sep 12, 2023
Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome Trial in Australia, Netherlands,
Recruiting
- Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome
-
Duarte, California
- +12 more
Jan 4, 2023
Chronic Lymphocytic Leukemia, Minimal Residual Disease Trial in Bath (Exercise trial)
Enrolling by invitation
- Chronic Lymphocytic Leukemia
- Minimal Residual Disease
- Exercise trial
-
Bath, Bath & Northeast Somerset, United Kingdom
- +1 more
Oct 20, 2021
Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance
Not yet recruiting
- Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
- (no location specified)
Dec 16, 2022
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia Trial in United Kingdom (Reduced intensity haplodentical
Active, not recruiting
- Hodgkin's Lymphoma
- +8 more
- Reduced intensity haplodentical stem cell transplant
- Myeloablative haploidentical stem cell transplant
-
Birmingham, United Kingdom
- +11 more
Sep 27, 2021
Acalabrutinib in Chronic Lymphocytic Leukaemia in United Kingdom
Recruiting
- Chronic Lymphocytic Leukemia, CLL
-
Aylesbury, United Kingdom
- +7 more
Jan 12, 2023
Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma Trial in India (Acalabrutinib capsule)
Active, not recruiting
- Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma
- Acalabrutinib capsule
-
Ahmedabad, India
- +12 more
Feb 2, 2023
Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- (no location specified)
Sep 18, 2023
Acute B-Cell Lymphoblastic Leukaemia Trial in Brazil (Spectrila®)
Recruiting
- Acute B-Cell Lymphoblastic Leukaemia
-
Belo Horizonte, Brazil
- +7 more
Aug 26, 2022
Acute Leukemia Trial in Hull
Completed
- Acute Leukemia
-
Hull, United KingdomHull University Teaching Hospital NHS Trust
Nov 7, 2022
Immunophenotypic Evaluation of IL-7R a in Acute Leukaemia
Not yet recruiting
- Benefit: To Patient Have Investigation for Diagnosis and Follow up for His Disease and Reach to New Method Help in Early Diagnosis of Lymphoid Disorder
- (no location specified)
Nov 30, 2022
Pneumococcal Vaccination in Chronic Lymphocytic Leukaemia
Recruiting
- Pneumococcal Infections
- +3 more
- Prevnar13
-
Amsterdam-Zuidoost, NetherlandsAmsterdam UMC Locatie AMC
Dec 3, 2021
Acute Myeloid Leukaemia Trial in Worldwide (S 64315 (also referred as MIK665) and azacitidine)
Active, not recruiting
- Acute Myeloid Leukaemia
- S 64315 (also referred as MIK665) and azacitidine
-
Houston, Texas
- +6 more
Dec 16, 2022
Acute Myeloid Leukaemia Trial in Australia, France, United States (S 64315 (also referred as MIK665) and venetoclax)
Terminated
- Acute Myeloid Leukaemia
- S 64315 (also referred as MIK665) and venetoclax
-
New Haven, Connecticut
- +6 more
Dec 20, 2022
The Acute Promyelocytic Leukaemia Asian Consortium Project
Recruiting
- Acute Promyelocytic Leukemia
-
Hong Kong, Hong KongDepartment of Medicine, the University of Hong Kong, Queen Mary
Oct 3, 2022
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory, Acute Lymphoblastic Leukemia, in Relapse Trial in Hangzhou (CD19/BCMA
Recruiting
- Multiple Myeloma in Relapse
- +5 more
- CD19/BCMA Targeted CAR T-cells and dasatinib
- CD19/BCMA Targeted CAR T-cells
-
Hangzhou, Zhejiang, ChinaThe First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Oct 27, 2020
Acute Lymphoblastic Leukaemia - Category Trial in Leicester (Ciprofloxacin, Antibiotic)
Recruiting
- Acute Lymphoblastic Leukaemia - Category
-
Leicester, United KingdomLeicester Royal Infirmary
Jul 5, 2022
Relapsed Acute Myeloid Leukaemia Trial (Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))
Not yet recruiting
- Relapsed Acute Myeloid Leukaemia
- Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL)
- (no location specified)
Jul 4, 2023
B-cell Acute Lymphocytic Leukemia Trial in Suzhou (CD19 CAR-T cells)
Recruiting
- B-cell Acute Lymphocytic Leukemia
- CD19 CAR-T cells
-
Suzhou, ChinaThe First Affiliated Hospital of Soochow University
Jan 11, 2023
Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
-
Nantes, FranceCHU de Nantes
Jan 24, 2023
Retention Rate of Acalabrutinib in a Non-interventional Setting
Recruiting
- Chronic Lymphocytic Leukaemia (CLL)
-
Zittau, GermanyResearch Site
Jan 12, 2023
Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19
Recruiting
- Lymphoblastic Leukemia
- +5 more
- Anti-CD19 CAR T-cells
-
Singapore, Singapore
- +1 more
Dec 4, 2022
Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)
Recruiting
- Cancer
- +4 more
- INKmune
-
Athens, Attiki, Greece
- +2 more
Jul 3, 2023
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Scottsdale, Rochester (Biospecimen Collection, Cardiopulmonary
Recruiting
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Biospecimen Collection
- +8 more
-
Scottsdale, Arizona
- +1 more
May 16, 2023